I'm saying it's not worth a surge of 10%.
It's not worth people saying "soon $1 and then $10".
It's not news that "indicates the cells work", it's not news that indicates "the FDA are serious about approving for aGVHD" (especially considering this a completely different product).
That's the Pom Pom waving, and if you look back through the comments it's easy to find.
Sure, be happy, but be realistic. Or at least be open to the voices of those who are.
Ann: FDA Grants Orphan Drug Designation for Revascor, page-127
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
-0.075(5.12%) |
Mkt cap ! $1.587B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.37 | $9.337M | 6.672M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 80200 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 28642 | 2 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |